| abstract |
PCT No. PCT/SE97/01097 Sec. 371 Date Jul. 31, 1997 Sec. 102(e) Date Jul. 31, 1997 PCT Filed Jun. 18, 1997 PCT Pub. No. WO97/49681 PCT Pub. Date Dec. 31, 1997This invention relates to a novel form of the HMG-CoA reductase inhibitor fluvastatin, more specifically to a highly crystalline form of fluvastatin sodium, referred to as fluvastatin sodium form B. The invention also relates to processes for production of fluvastatin sodium form B, to pharmaceutical compositions comprising fluvastatin sodium form B, and to the use of fluvastatin sodium form B in medical treatment. |